- Home
- KOSS vs RAPT Comparison
KOSS vs RAPT Comparison
Compare KOSS & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- RAPT
- Stock Information
- Founded
- KOSS 1953
- RAPT 2015
- Country
- KOSS United States
- RAPT United States
- Employees
- KOSS N/A
- RAPT N/A
- Industry
- KOSS Consumer Electronics/Appliances
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- KOSS Consumer Staples
- RAPT Health Care
- Exchange
- KOSS Nasdaq
- RAPT Nasdaq
- Market Cap
- KOSS 68.4M
- RAPT 59.1M
- IPO Year
- KOSS N/A
- RAPT 2019
- Fundamental
- Price
- KOSS $6.62
- RAPT $1.20
- Analyst Decision
- KOSS
- RAPT Hold
- Analyst Count
- KOSS 0
- RAPT 10
- Target Price
- KOSS N/A
- RAPT $6.00
- AVG Volume (30 Days)
- KOSS 148.4K
- RAPT 9.1M
- Earning Date
- KOSS 01-30-2025
- RAPT 03-06-2025
- Dividend Yield
- KOSS N/A
- RAPT N/A
- EPS Growth
- KOSS N/A
- RAPT N/A
- EPS
- KOSS N/A
- RAPT N/A
- Revenue
- KOSS $12,092,999.00
- RAPT N/A
- Revenue This Year
- KOSS N/A
- RAPT N/A
- Revenue Next Year
- KOSS N/A
- RAPT N/A
- P/E Ratio
- KOSS N/A
- RAPT N/A
- Revenue Growth
- KOSS N/A
- RAPT N/A
- 52 Week Low
- KOSS $2.27
- RAPT $0.79
- 52 Week High
- KOSS $18.73
- RAPT $27.35
- Technical
- Relative Strength Index (RSI)
- KOSS 38.21
- RAPT 43.92
- Support Level
- KOSS $6.58
- RAPT $1.07
- Resistance Level
- KOSS $7.27
- RAPT $1.29
- Average True Range (ATR)
- KOSS 0.45
- RAPT 0.17
- MACD
- KOSS -0.14
- RAPT -0.04
- Stochastic Oscillator
- KOSS 3.48
- RAPT 15.43
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.